Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma
出版年份 2019 全文链接
标题
Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma
作者
关键词
-
出版物
Frontiers in Oncology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-11-01
DOI
10.3389/fonc.2019.01150
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation
- (2019) Fei Liu et al. JOURNAL OF NEURO-ONCOLOGY
- NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach
- (2019) Bekos et al. Cancers
- Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression
- (2018) Fernanda Marconi Roversi et al. BIOMEDICINE & PHARMACOTHERAPY
- GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer
- (2018) Dan Zhao et al. BMC CANCER
- Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients
- (2018) Venus Dalal et al. CLINICA CHIMICA ACTA
- A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
- (2018) Chanhee Han et al. GYNECOLOGIC ONCOLOGY
- Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells
- (2018) Koji Yamamoto et al. Oncotarget
- Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors
- (2018) Fawen Chen et al. Cancer Management and Research
- Genomic atlas of the human plasma proteome
- (2018) Benjamin B. Sun et al. NATURE
- A combined score of clinical factors and serum proteins can predict time to recurrence in high grade serous ovarian cancer
- (2018) David Mysona et al. GYNECOLOGIC ONCOLOGY
- Complementarity of SOMAscan to LC-MS/MS and RNA-seq for quantitative profiling of human embryonic and mesenchymal stem cells
- (2017) Anja M. Billing et al. Journal of Proteomics
- Proteotranscriptomics Reveal Signaling Networks in the Ovarian Cancer Microenvironment
- (2017) Thomas Worzfeld et al. MOLECULAR & CELLULAR PROTEOMICS
- Erratum: Connecting genetic risk to disease end points through the human blood plasma proteome
- (2017) Karsten Suhre et al. Nature Communications
- Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
- (2017) Oliver M.T. Pearce et al. Cancer Discovery
- The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
- (2017) Thomas Worzfeld et al. Frontiers in Oncology
- Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses
- (2016) Robert L. Coleman et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies
- (2016) Wanglei Qu et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up
- (2016) Paul F. Pinsky et al. GYNECOLOGIC ONCOLOGY
- Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer
- (2016) Archana R. Simmons et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- Can advanced-stage ovarian cancer be cured?
- (2016) Steven Narod Nature Reviews Clinical Oncology
- The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization
- (2016) Florian Finkernagel et al. Oncotarget
- Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma
- (2015) Soonyean Hwang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Proteome–Metabolome Profiling of Ovarian Cancer Ascites Reveals Novel Components Involved in Intercellular Communication
- (2014) Victoria O. Shender et al. MOLECULAR & CELLULAR PROTEOMICS
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
- (2014) Erika Assarsson et al. PLoS One
- Beyond antibodies: New affinity reagents to unlock the proteome
- (2014) Bridget Lollo et al. PROTEOMICS
- Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
- (2013) Silke Reinartz et al. INTERNATIONAL JOURNAL OF CANCER
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
- (2011) H. Kulbe et al. CANCER RESEARCH
- Protein biomarkers of ovarian cancer: the forest and the trees
- (2011) Brian M Nolen et al. Future Oncology
- Comparison of candidate serologic markers for type I and type II ovarian cancer
- (2011) Dan Lu et al. GYNECOLOGIC ONCOLOGY
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- In-Depth Proteomics of Ovarian Cancer Ascites: Combining Shotgun Proteomics and Selected Reaction Monitoring Mass Spectrometry
- (2011) Sarah Elschenbroich et al. JOURNAL OF PROTEOME RESEARCH
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
- (2011) Larry Gold et al. PLoS One
- From SOMAmer-Based Biomarker Discovery to Diagnostic and Clinical Applications: A SOMAmer-Based, Streamlined Multiplex Proteomic Assay
- (2011) Stephan Kraemer et al. PLoS One
- Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum
- (2010) Melissa S. DeRycke et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
- (2010) Chi-Wen Lo et al. CANCER RESEARCH
- Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer
- (2010) Wenjie Dong et al. INTERNATIONAL JOURNAL OF CANCER
- PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium
- (2009) Huaiyu Mi et al. NUCLEIC ACIDS RESEARCH
- Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer
- (2009) Suraj D. Amonkar et al. PLoS One
- The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
- (2009) Patrick O. Brown et al. PLOS MEDICINE
- An Epigenetic Genome-Wide Screen Identifies SPINT2 as a Novel Tumor Suppressor Gene in Pediatric Medulloblastoma
- (2008) P. N. Kongkham et al. CANCER RESEARCH
- Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers
- (2008) Cynthia Kuk et al. MOLECULAR & CELLULAR PROTEOMICS
- A Proteome Resource of Ovarian Cancer Ascites: Integrated Proteomic and Bioinformatic Analyses To Identify Putative Biomarkers
- (2007) Limor Gortzak-Uzan et al. JOURNAL OF PROTEOME RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now